O'Shaughnessy Asset Management, LLC Aclaris Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $3,533 - $5,325	-288 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$13.38 - $18.8 $468 - $658	-35 Reduced 10.84%	288 $5,000
Q2 2021 Aug 09, 2021	SELL	$17.08 - $29.6 $23,758 - $41,173	-1,391 Reduced 81.16%	323 $6,000
Q1 2021 May 14, 2021	BUY	$5.86 - $27.73 $222 - $1,053	38 Added 2.27%	1,714 $43,000
Q4 2020 Feb 11, 2021	BUY	$2.65 - $7.61 $858 - $2,465	324 Added 23.96%	1,676 $11,000
Q2 2020 Aug 13, 2020	BUY	$1.04 - $1.73 $1,406 - $2,338	1,352 New	1,352 $2,000
Q1 2020 May 13, 2020	SELL	$0.75 - $2.18 $4,369 - $12,700	-5,826 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$1.02 - $1.97 $5,942 - $11,477	5,826 New	5,826 $11,000

100

52.2M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $78.7M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.